Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials

The clinical benefits of endocrine therapy for patients with hormonosensitive breast cancer are well established. For many years, 5 years of tamoxifen was the gold standard of adjuvant treatment. The recent development of new endocrine agents provides physicians with a more effective therapeutic app...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Abrial, Catherine, Durando, Xavier, Mouret-Reynier, Marie-Ange, Thivat, Emilie, Bayet-Robert, Mathilde, Nayl, Béatrice, Dubray, Pascale, Pomel, Christophe, Chollet, Philippe, Penault-Llorca, F
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2840558/
https://ncbi.nlm.nih.gov/pubmed/20360896
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares